Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.13 +0.21%   SPY: 134.79 +0.25%
Quote Spy BCRX NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Biocryst Pharmaceuticals (BCRX)

@ 4:00 PM
Click the portfolio to add BCRX:
Close [X]
+ Add BCRX to Portfolio
  
  Last Trade: $3.87 -0.06 (-1.53%)
  Volume: 177,002 63% of avg daily volume
       
  Avg Volume: 281,418
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 3.85 - 3.99
  Open: 3.95
  Previous Close: 3.93
  52-wk Range: 2.28 - 4.49
  Market Cap: 177.6M
  P/E: -3.3
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (-0.5%)
Cancer Stocks (-0.5%)
Swine Flu and Bird F... (+0.4%)
Spy BCRX

? Pro holders
? Member holders
? Items submitted
Additional BCRX resources



Customize Links
To see which Pros and tickerspy members own BCRX Sign up now
Latest BCRX Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Swine Flu Has BioPharma as Happy as Pigs in Filth
BCRX  NVAX  
Linked by Benzinga.com - January 23, 01:18PM from (www.benzinga.com)
It seems crass to be discussing the success for small BioPharma companies when human beings are suffering, but such is nature  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BioCryst Experimental Gout Drug Helps Patients in Clinical Trial
BCRX  
Linked by Bloomberg - November 08, 07:00AM from (www.bloomberg.com)
BioCryst Pharmaceuticals Inc. (BCRX) said a study showed that adding its experimental drug for gout to a standard therapy  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Swine Flu Variation Emerges With Power to Resist Drugs, Researchers Say
BCRX  
Linked by Bloomberg - June 09, 07:02PM from (www.bloomberg.com)
A novel form of the swine flu virus that swept the globe in 2009 has emerged in Australia and Singapore, carrying a genetic  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
6 Stocks At 52-Week Lows
AIBYY  BCRX  JRJC  GNK  HGG  DGW  
Linked by Investopedia Stock Analysis - January 31, 01:08PM from (stocks.investopedia.com)
Are these companies on a downward spiral or gearing up for a rebound?  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BioCryst to Present New Data for BCX4208 Monotherapy at the 74th Annual American College of Rheumatology (ACR) Scientific Meeting
BCRX  
Linked by BusinessWire - November 08, 06:30AM from (www.businesswire.com)
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced the presentation of new data related to the efficacy and safety  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BioCryst Reports Third Quarter 2010 Financial Results and Provides Corporate Update
BCRX  
Linked by BusinessWire - October 28, 06:40AM from (www.businesswire.com)
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the third quarter and nine months ended  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BioCryst Pharmaceuticals to Announce Third Quarter 2010 Financial Results on October 28, 2010
BCRX  
Linked by BusinessWire - October 18, 06:45AM from (www.businesswire.com)
BioCryst Pharmaceuticals (NASDAQ:BCRX) today announced that its third quarter 2010 financial results will be released on  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BCRX - Pivotal trial results fail to impress(report)
BCRX  
Linked by Chasing the Alpha - September 20, 09:45PM from (www.chasingthealpha.com)

For BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), this could have been a better week. Today, they reported top-line  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BioCryst’s Partner Green Cross Receives Marketing & Manufacturing Approval for Peramivir in South Korea
BCRX  
Linked by BusinessWire - August 16, 06:45AM from (www.businesswire.com)
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that its partner, Green Cross Corporation has received marketing  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource